Unipath Specialty Laboratory (Mehsana) L Lp Profile
Key Indicators
- Obligation of Contribution ₹ 10.00 K
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 M
About Unipath Specialty Laboratory (Mehsana) L Lp
Unipath Specialty Laboratory (Mehsana) L Lp (USLMLL) is 5 Year, 9 Months old Limited Liability Partnership 29 April 2019. Its registered office is in Mahesana, Gujarat, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 10.00 K as per MCA.
Company Details
- Location
Mahesana, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN/FCRN
AAP-1110
- Incorporation Date
29 Apr 2019
- Date of Accounts and Solvency Statement
31 Mar 2023
- ROC Code
Roc-Ahmedabad
- Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Unipath Specialty Laboratory (Mehsana) L Lp?
Designated Partners (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jwalant Shah  | Designated Partner | 29-Apr-2019 | Current |
| Rakeshkumar Pimpaldara | Designated Partner | 29-Apr-2019 | Current |
| Vipulkumar Prajapati | Designated Partner | 29-Apr-2019 | Current |
Financial Performance of Unipath Specialty Laboratory (Mehsana) L Lp.
Enhance accessibility to Unipath Specialty Laboratory (Mehsana) L Lp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Unipath Specialty Laboratory (Mehsana) L Lp?
Unlock access to Unipath Specialty Laboratory (Mehsana) L Lp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Advanced Transfusion Medicine Research FoundationJwalant Shah is a mutual person
Unipath Specialty Laboratory (Gujarat) L LpJwalant Shah is a mutual person
- Unipath Specialty Laboratory (Gota) Llp
Jwalant Shah is a mutual person
- Unipath Specialty Laboratory Limited
Jwalant Shah is a mutual person
Qure Hematology And Oncology Center LlpJwalant Shah is a mutual person
- Unipath Specialty Laboratory (Baroda) Ll P
Jwalant Shah is a mutual person
Charges (Loans)
₹1,000,000.00
₹0
Charges Breakdown by Lending Institutions
- Indusind Bank Ltd. : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jul 2019 | Indusind Bank Ltd. | ₹1.00 M | Open |
How Many Employees Work at Unipath Specialty Laboratory (Mehsana) L Lp?
Unipath Specialty Laboratory (Mehsana) L Lp has a workforce of 31 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unipath Specialty Laboratory (Mehsana) L Lp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unipath Specialty Laboratory (Mehsana) L Lp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
